MetaVia MTVA
NASDAQ MTVA
$1.46 +0.02 (+1.39%)
At close: Aug 21, 2026 · 4:00 PM EDT

MetaVia (MTVA) Cash from Investing Activities (2019 - 2024)

MetaVia's (MTVA) quarterly Cash from Investing Activities came in at -$3000.0 in Q2 2024, up 40.0% on a QoQ basis from -$5000.0 in Q1 2024.

MetaVia (MTVA) Cash from Investing Activities (2019 - 2024) Analysis & Trends

MetaVia (MTVA) has 5 years of Cash from Investing Activities data on file, last reported at -$3000.0 in Q2 2024.

  • Quarterly Cash from Investing Activities changed N/A year-over-year to -$3000.0 in Q2 2024, while the trailing twelve-month figure through Sep 2025 was -$3000.0 (up 82.35% YoY) and the FY2025 annual result came in at -$2000.0, up 75.0% from the prior year.
  • Cash from Investing Activities rose to -$3000.0 in Q2 2024, from -$5000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $71000.0 in Q4 2020 to a low of -$583000.0 in Q4 2021.
  • A 4-year average of -$71500.0 and a median of -$4500.0 in 2023 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2020 — Cash from Investing Activities soared 101.2% — and 2021, when it sank 921.13%.
  • Tracing MTVA's Cash from Investing Activities over 4 years: stood at $71000.0 in 2020, then slumped by 921.13% to -$583000.0 in 2021, then surged by 98.46% to -$9000.0 in 2023, then soared by 66.67% to -$3000.0 in 2024.
  • The last three Cash from Investing Activities figures came in at -$3000.0 (Q2 2024), -$5000.0 (Q1 2024), and -$9000.0 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -45.80 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -92.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 329.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -49.35 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -363.46 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -3.17 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 24.51 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -229.72 Mn
10 MetaVia 8.72 Mn -3.92 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2024 -3,000.00
Jun 30, 2024 -3,000.00
Mar 31, 2024 -5,000.00
Mar 31, 2024 -5,000.00
Dec 31, 2023 -9,000.00
Dec 31, 2023 -9,000.00
Sep 30, 2023 -37,000.00
Sep 30, 2023 -37,000.00
Mar 31, 2023 -4,000.00
Mar 31, 2023 -4,000.00
Dec 31, 2021 -583,000.00
Dec 31, 2021 -583,000.00
Dec 31, 2020 71,000.00
Dec 31, 2020 71,000.00
Mar 31, 2020 -2,000.00
Mar 31, 2020 -2,000.00
Dec 31, 2019 -5.94 Mn
Dec 31, 2019 -5.94 Mn
Sep 30, 2019 -93,000.00
Sep 30, 2019 -93,000.00